Pengo V - Search Results

1

Risk-based secondary prevention of obstetric antiphospholipid syndrome.

Ruffatti A, Calligaro A, Del Ross T, Favaro M, Tonello M, Banzato A, Punzi L, Pengo V. Ruffatti A, et al. Among authors: pengo v. Lupus. 2012 Jun;21(7):741-3. doi: 10.1177/0961203312446388. Lupus. 2012. PMID: 22635219

2

A brief contact of native whole blood with adenosine diphosphate (ADP) promotes the release of the contents of platelet alpha granules but not dense bodies and increases platelet retention to glass bead columns.

Pengo V, Boschello M, Baca M, Marzari A, Banzato A, Ferrari G, Shivazappa L, Dalla Volta S. Pengo V, et al. Folia Haematol Int Mag Klin Morphol Blutforsch. 1990;117(3):359-64. Folia Haematol Int Mag Klin Morphol Blutforsch. 1990. PMID: 1703103

3

Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome.

Ostuni PA, Lazzarin P, Pengo V, Ruffatti A, Schiavon F, Gambari P. Ostuni PA, et al. Among authors: pengo v. Ann Rheum Dis. 1990 Mar;49(3):184-7. doi: 10.1136/ard.49.3.184. Ann Rheum Dis. 1990. PMID: 2108619 Free PMC article.

4

[Advantages of a cardiologic ambulatory care facility specifically organized for patients undergoing treatment with oral anticoagulant drugs].

Pengo V, Peruzzi P, Marzari A, Zanon F, Banzato A, Schivazappa L. Pengo V, et al. G Ital Cardiol. 1989 Dec;19(12):1125-8. G Ital Cardiol. 1989. PMID: 2561357 Italian.

5

Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation.

Pengo V, Banzato A, Garelli E, Zasso A, Biasiolo A. Pengo V, et al. Blood Coagul Fibrinolysis. 1993 Oct;4(5):739-41. Blood Coagul Fibrinolysis. 1993. PMID: 8292723 Clinical Trial.

6

Anti beta 2-glycoprotein I antibodies in a patient with catastrophic antiphospholipid syndrome.

Pengo V, Biasiolo A, Grazia Fior M, Ruffatti A. Pengo V, et al. Clin Rheumatol. 1995 Nov;14(6):646-9. doi: 10.1007/BF02207930. Clin Rheumatol. 1995. PMID: 8608682

7

Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.

Pengo V, Biasiolo A, Brocco T, Tonetto S, Ruffatti A. Pengo V, et al. Thromb Haemost. 1996 May;75(5):721-4. Thromb Haemost. 1996. PMID: 8725712

8

Immunosuppressive treatment in a heart transplantation candidate with antiphospholipid syndrome.

Pengo V, Biasiolo A, Marson P, De Silvestro G, Agostini C, Livi U. Pengo V, et al. Clin Rheumatol. 1996 Sep;15(5):504-7. doi: 10.1007/BF02229652. Clin Rheumatol. 1996. PMID: 8894368

9

A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses.

Pengo V, Barbero F, Banzato A, Garelli E, Noventa F, Biasiolo A, Zasso A, Dalla Volta S. Pengo V, et al. Thromb Haemost. 1997 May;77(5):839-44. Thromb Haemost. 1997. PMID: 9184389 Clinical Trial.

10

Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.

Pengo V, Zasso A, Barbero F, Banzato A, Nante G, Parissenti L, John N, Noventa F, Dalla Volta S. Pengo V, et al. Am J Cardiol. 1998 Aug 15;82(4):433-7. doi: 10.1016/s0002-9149(98)00357-9. Am J Cardiol. 1998. PMID: 9723629 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

461 results

Search Page

Filters